Uranium Royalty (NASDAQ:UROY – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.01) by $0.02, Zacks reports. Uranium Royalty had a negative return on equity of 1.26% and a net margin of 1.95%.The company had revenue of $12.25 million for the quarter.
Uranium Royalty Stock Down 0.1%
Shares of NASDAQ:UROY traded down $0.01 on Wednesday, hitting $3.82. The stock had a trading volume of 474,603 shares, compared to its average volume of 3,124,266. The firm’s 50 day moving average price is $4.24 and its 200-day moving average price is $3.96. Uranium Royalty has a twelve month low of $1.43 and a twelve month high of $5.52.
Wall Street Analyst Weigh In
A number of research analysts recently commented on the stock. Zacks Research lowered shares of Uranium Royalty from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 26th. Raymond James Financial reissued a “market perform” rating on shares of Uranium Royalty in a research report on Wednesday, January 14th. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Uranium Royalty in a report on Wednesday, January 21st. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $4.50.
Institutional Investors Weigh In On Uranium Royalty
A number of hedge funds and other institutional investors have recently bought and sold shares of UROY. Goldman Sachs Group Inc. lifted its position in shares of Uranium Royalty by 25.4% during the first quarter. Goldman Sachs Group Inc. now owns 104,243 shares of the company’s stock worth $183,000 after purchasing an additional 21,118 shares in the last quarter. Thompson Davis & CO. Inc. bought a new position in shares of Uranium Royalty in the second quarter valued at about $33,000. Vident Advisory LLC boosted its position in shares of Uranium Royalty by 47.1% in the second quarter. Vident Advisory LLC now owns 1,480,151 shares of the company’s stock valued at $3,700,000 after acquiring an additional 474,030 shares during the period. Corient Private Wealth LLC acquired a new position in shares of Uranium Royalty during the 2nd quarter worth approximately $29,000. Finally, BNP Paribas Financial Markets acquired a new position in Uranium Royalty in the 3rd quarter valued at $128,000. 24.19% of the stock is owned by institutional investors and hedge funds.
Uranium Royalty Company Profile
Uranium Royalty Corp. is a Vancouver-based mineral rights acquisition, royalty and streaming company focused exclusively on the uranium sector. Established in early 2021 and listed on the NASDAQ under the symbol UROY, the company seeks to provide investors with leveraged exposure to uranium prices without direct mining risk. Rather than owning or operating mines, Uranium Royalty acquires long-term royalties and streams on both production and development-stage uranium projects worldwide.
The company’s diversified portfolio encompasses royalty interests across multiple jurisdictions, including Canada, the United States, South America, Central Asia and Australia.
See Also
- Five stocks we like better than Uranium Royalty
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Uranium Royalty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uranium Royalty and related companies with MarketBeat.com's FREE daily email newsletter.
